Premium
Phenotypic expression of familial amyloid polyneuropathy in Brazil
Author(s) -
Bittencourt P. L.,
Couto C. A.,
Clemente C.,
Farias A. Q.,
Palácios S. A.,
Mies S.,
Goldberg A. C.
Publication year - 2005
Publication title -
european journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.881
H-Index - 124
eISSN - 1468-1331
pISSN - 1351-5101
DOI - 10.1111/j.1468-1331.2004.00941.x
Subject(s) - medicine , transthyretin , penetrance , amyloidosis , amyloid polyneuropathy , polyneuropathy , age of onset , disease , phenotype , clinical phenotype , peripheral neuropathy , gastroenterology , pediatrics , endocrinology , genetics , diabetes mellitus , gene , biology
Familial amyloid polyneuropathy (FAP) is an inherited amyloidosis mainly associated with transthyretin Val30Met variant. Clinical heterogeneity has been reported in different populations with FAP and Va130Met variant. In order to characterize FAP expression in Brazilians and to compare its features to those reported in other cohorts, 44 Brazilian patients (27 females, median age 36 [23–53] years) with FAP and the Val30Met variant were investigated. Approximately 40% of their family members, with the exception, of parents and siblings, had FAP. Most of the patients had symptoms of peripheral neuropathy at onset. Median age at onset was 32 [20–44] years. Earlier onset was observed in males (27 [20–43] years in males vs. 33 [20–44] years in females, P = 0.02) and in patients whose parents had FAP (31 [20–44] years vs. 40 [37–43] years in patients, respectively with and without affected parents, P = 0.03). Phenotypic expression of FAP in Brazil is similar to the one reported in Portugal, characterized by high disease penetrance, early onset, particularly in males and in subjects with affected parents, and major symptoms of peripheral neuropathy. These data highlight the influence of common genetic factors, shared by both groups of patients, in disease expression.